DK0975761T3 - Humant, rekombinant beta-interferon med forbedret opløselighed - Google Patents
Humant, rekombinant beta-interferon med forbedret opløselighedInfo
- Publication number
- DK0975761T3 DK0975761T3 DK98920533T DK98920533T DK0975761T3 DK 0975761 T3 DK0975761 T3 DK 0975761T3 DK 98920533 T DK98920533 T DK 98920533T DK 98920533 T DK98920533 T DK 98920533T DK 0975761 T3 DK0975761 T3 DK 0975761T3
- Authority
- DK
- Denmark
- Prior art keywords
- phe
- leu
- interferon
- human
- improved solubility
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19717864A DE19717864C2 (de) | 1997-04-23 | 1997-04-23 | Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung |
PCT/EP1998/002238 WO1998048018A1 (de) | 1997-04-23 | 1998-04-16 | HUMANES, REKOMBINANTES INTERFERON-β MIT VERBESSERTER LÖSLICHKEIT |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0975761T3 true DK0975761T3 (da) | 2004-02-16 |
Family
ID=7827959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98920533T DK0975761T3 (da) | 1997-04-23 | 1998-04-16 | Humant, rekombinant beta-interferon med forbedret opløselighed |
Country Status (10)
Country | Link |
---|---|
US (3) | US6572853B1 (da) |
EP (1) | EP0975761B1 (da) |
JP (1) | JP4189035B2 (da) |
AT (1) | ATE257859T1 (da) |
CA (1) | CA2287521C (da) |
DE (2) | DE19717864C2 (da) |
DK (1) | DK0975761T3 (da) |
ES (1) | ES2214709T3 (da) |
PT (1) | PT975761E (da) |
WO (1) | WO1998048018A1 (da) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19717864C2 (de) * | 1997-04-23 | 2001-05-17 | Fraunhofer Ges Forschung | Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung |
US20080076706A1 (en) | 1997-07-14 | 2008-03-27 | Bolder Biotechnology, Inc. | Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof |
NZ502375A (en) | 1997-07-14 | 2001-11-30 | Bolder Biotechnology Inc | The addition of non-natural cysteine derivatives to cause the protein to act as antagonists of the GH family |
US6753165B1 (en) | 1999-01-14 | 2004-06-22 | Bolder Biotechnology, Inc. | Methods for making proteins containing free cysteine residues |
US8288126B2 (en) | 1999-01-14 | 2012-10-16 | Bolder Biotechnology, Inc. | Methods for making proteins containing free cysteine residues |
US6514729B1 (en) * | 1999-05-12 | 2003-02-04 | Xencor, Inc. | Recombinant interferon-beta muteins |
US7144574B2 (en) | 1999-08-27 | 2006-12-05 | Maxygen Aps | Interferon β variants and conjugates |
US6531122B1 (en) | 1999-08-27 | 2003-03-11 | Maxygen Aps | Interferon-β variants and conjugates |
US7431921B2 (en) | 2000-04-14 | 2008-10-07 | Maxygen Aps | Interferon beta-like molecules |
YU48703A (sh) | 2001-02-27 | 2006-05-25 | Maxygen Aps | Novi interferonu beta-slični molekuli |
AU2003254641A1 (en) * | 2002-08-28 | 2004-03-19 | Maxygen Aps | Interferon beta-like molecules for treatment of cancer |
CA2498319A1 (en) * | 2002-09-09 | 2004-03-18 | Nautilus Biotech | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
US20040137581A1 (en) * | 2002-10-01 | 2004-07-15 | Xencor | Interferon variants with improved properties |
WO2005003157A2 (en) * | 2003-06-10 | 2005-01-13 | Xencor, Inc. | Interferon variants with improved properties |
AU2005211362B2 (en) | 2004-02-02 | 2008-03-13 | Ambrx, Inc. | Modified human interferon polypeptides and their uses |
KR100781666B1 (ko) | 2004-11-02 | 2007-12-03 | 신영기 | 인간 인터페론-베타 변이체 |
WO2007110231A2 (en) * | 2006-03-28 | 2007-10-04 | Nautilus Biotech, S.A. | MODIFIED INTERFERON-β (IFN-β) POLYPEPTIDES |
EP2395099A3 (en) * | 2006-05-02 | 2012-05-16 | Allozyne, Inc. | Amino acid substituted molecules |
WO2008137471A2 (en) | 2007-05-02 | 2008-11-13 | Ambrx, Inc. | Modified interferon beta polypeptides and their uses |
SG188143A1 (en) | 2008-02-08 | 2013-03-28 | Ambrx Inc | Modified leptin polypeptides and their uses |
DE102008051574A1 (de) | 2008-10-14 | 2010-04-15 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zur Herstellung von Interferon-beta und deren Varianten |
EP2431051A1 (en) * | 2010-09-15 | 2012-03-21 | Vakzine Projekt Management GmbH | Type-1 interferons for the treatment of multiple sclerosis |
SG10201602076QA (en) | 2011-10-01 | 2016-04-28 | Glytech Inc | Glycosylated polypeptide and pharmaceutical composition containing same |
CN104334574B (zh) | 2013-03-29 | 2020-01-14 | 株式会社糖锁工学研究所 | 附加唾液酸化糖链的多肽 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4588585A (en) * | 1982-10-19 | 1986-05-13 | Cetus Corporation | Human recombinant cysteine depleted interferon-β muteins |
GB8412564D0 (en) | 1984-05-17 | 1984-06-20 | Searle & Co | Structure and properties |
US5350836A (en) * | 1989-10-12 | 1994-09-27 | Ohio University | Growth hormone antagonists |
DE19717864C2 (de) * | 1997-04-23 | 2001-05-17 | Fraunhofer Ges Forschung | Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung |
-
1997
- 1997-04-23 DE DE19717864A patent/DE19717864C2/de not_active Expired - Fee Related
-
1998
- 1998-04-16 CA CA002287521A patent/CA2287521C/en not_active Expired - Lifetime
- 1998-04-16 WO PCT/EP1998/002238 patent/WO1998048018A1/de active IP Right Grant
- 1998-04-16 ES ES98920533T patent/ES2214709T3/es not_active Expired - Lifetime
- 1998-04-16 DK DK98920533T patent/DK0975761T3/da active
- 1998-04-16 US US09/403,532 patent/US6572853B1/en not_active Expired - Lifetime
- 1998-04-16 PT PT98920533T patent/PT975761E/pt unknown
- 1998-04-16 AT AT98920533T patent/ATE257859T1/de active
- 1998-04-16 JP JP54497598A patent/JP4189035B2/ja not_active Expired - Lifetime
- 1998-04-16 EP EP98920533A patent/EP0975761B1/de not_active Expired - Lifetime
- 1998-04-16 DE DE59810596T patent/DE59810596D1/de not_active Expired - Lifetime
-
2003
- 2003-05-30 US US10/448,667 patent/US7052687B2/en not_active Expired - Lifetime
-
2005
- 2005-11-17 US US11/280,997 patent/US7575894B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE19717864A1 (de) | 1998-10-29 |
US20060093579A1 (en) | 2006-05-04 |
JP2001523957A (ja) | 2001-11-27 |
EP0975761B1 (de) | 2004-01-14 |
EP0975761A1 (de) | 2000-02-02 |
CA2287521A1 (en) | 1998-10-29 |
DE19717864C2 (de) | 2001-05-17 |
US7052687B2 (en) | 2006-05-30 |
US6572853B1 (en) | 2003-06-03 |
WO1998048018A1 (de) | 1998-10-29 |
JP4189035B2 (ja) | 2008-12-03 |
PT975761E (pt) | 2004-05-31 |
DE59810596D1 (de) | 2004-02-19 |
ES2214709T3 (es) | 2004-09-16 |
CA2287521C (en) | 2009-08-11 |
US7575894B2 (en) | 2009-08-18 |
US20040022763A1 (en) | 2004-02-05 |
ATE257859T1 (de) | 2004-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0975761T3 (da) | Humant, rekombinant beta-interferon med forbedret opløselighed | |
ES2124685T3 (es) | Variantes del inhibidor de la tripsina pancreatica bovina, su produccion y uso. | |
ATE402957T1 (de) | Analoge des menschlichen interferon-alpha mit niedriger toxizität | |
DE69435049D1 (de) | Chimäre proteine zur vermeidung der komplementaktivierung | |
DK0535091T3 (da) | Knogleinducerende farmaceutiske formuleringer | |
HU9200548D0 (en) | Improved activity process of recombined proteins | |
ZA942729B (en) | Modified protein and peptide pharmaceuticals. | |
GB8700204D0 (en) | Pancreatic secretory trypsin inhibitor & variants | |
ATE194917T1 (de) | Flüssige beta-interferon formulierungen | |
MX167236B (es) | Peptidos sinteticos de timosina -1 y metodo para su obtencion | |
DE59108947D1 (de) | Neues menschliches, rekombinantes interferon gamma | |
ES8900018A1 (es) | Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos inhibidores de la renina y de las proteasas acidas | |
ATE105841T1 (de) | 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen. | |
ES2033212A6 (es) | Procedimiento para la obtencion de peptidos puramente glicosilados, parcialmente glicosilados o no glicosilados. | |
DK595187A (da) | Minactivin og fremgangsmaade til fremstilling deraf | |
ATE224403T1 (de) | Verwendung von kaseinfragmenten als wachstumerförderer | |
EP0296227A4 (en) | ADMINISTRATION OF AMINOACIDS BY NASAL ROUTE. | |
AR243865A1 (es) | Procedimientos para fabricar derivados de aminoacidos; y silil derivados de aminoacidos utiles como intermediarios en dicho procedimiento. | |
AU1454495A (en) | Recombinant production of modified proteins lacking certain amino acids | |
AU4426689A (en) | Recombinant polypeptides of the hemorragic septicemy virus of fish | |
IT8748754A0 (it) | Procedimento per la produzione di pool di aminoacidi mediante idrolisi enzimatica di substrati proteici naturali |